| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9baf3defa9dc998356da178a79d4920 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
| filingDate |
2005-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eff510acc2a6c9de9d244107681cfe58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83f3f518ad298e252650607a449cf2f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4df43a316cc96406b1377c3480f953 |
| publicationDate |
2009-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2327435-T3 |
| titleOfInvention |
A BIOLOGICAL MARKER FOR IMFLAMATION. |
| abstract |
A method for determining the efficacy of an anti-inflammatory therapeutic treatment of a subject to which A3AR agonist has been administered, comprising determining the level of A3AR expression in peripheral blood mononuclear cell (PBMNC) samples of the subject, in two or more successive moments, at least one of which is performed during an anti-inflammatory treatment, in which a difference in the level of expression is indicative of the efficacy of the drug treatment. |
| priorityDate |
2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |